Chapter 1: HPV in the etiology of human cancer

Lowy, 2001, Fields virology, 2231

Doorbar, 2005, The papillomavirus life cycle, J Clin Virol, 32, S7, 10.1016/j.jcv.2004.12.006

Munger, 2004, Mechanisms of human papillomavirus-induced oncogenesis, J Virol, 78, 11451, 10.1128/JVI.78.21.11451-11460.2004

Longworth, 2004, Pathogenesis of human papillomaviruses in differentiating epithelia, Microbiol Mol Biol Rev, 68, 362, 10.1128/MMBR.68.2.362-372.2004

Thomas, 1999, The role of the E6-p53 interaction in the molecular pathogenesis of HPV, Oncogene, 18, 7690, 10.1038/sj.onc.1202953

Duensing, 2004, Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins, Int J Cancer, 109, 157, 10.1002/ijc.11691

Bernard, 2002, Gene expression of genital human papillomaviruses and considerations on potential antiviral approaches, Antivir Ther, 7, 219, 10.1177/135965350200700401

Bosch, 1995, Prevalence of human papillomavirus in cervical cancer: a worldwide perspective, J Natl Cancer Inst, 87, 796, 10.1093/jnci/87.11.796

Walboomers, 1999, Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J Pathol, 189, 12, 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F

Muñoz, 2004, Against which human papillomavirus types shall we vaccinate and screen? The international perspective, Int J Cancer, 111, 278, 10.1002/ijc.20244

Clifford, 2003, Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis, Br J Cancer, 88, 63, 10.1038/sj.bjc.6600688

IARC. IARC monographs on the evaluation of carcinogenic risks to humans. Human Papillomaviruses, vol. 64. Lyon: International Agency for Research on Cancer, 1995.

Muñoz, 2003, Epidemiologic classification of human papillomavirus types associated with cervical cancer, N Eng J Med, 348, 518, 10.1056/NEJMoa021641

Castellsagué, 2006, Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention, J Natl Cancer Inst, 98, 303, 10.1093/jnci/djj067

IARC Monographs on the evaluation of carcinogenic risks to humans. Human Papillomaviruses, vol. 90. Lyon: International Agency for Research on Cancer, In press.

Khan, 2005, The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice, J Natl Cancer Inst, 97, 1072, 10.1093/jnci/dji187

Winer, 2005, Development and duration of human papillomavirus lesions after initial infection, J Infect Dis, 191, 731, 10.1086/427557

Schiffman, 2005, The carcinogenicity of human papillomavirus types reflects viral evolution, Virology, 337, 76, 10.1016/j.virol.2005.04.002

Bosch, 2002, The causal relation between human papillomavirus and cervical cancer, J Clin Pathol, 55, 244, 10.1136/jcp.55.4.244

Kreimer, 2005, Human papillomavirus types in head and neck SCCs worldwide: a systematic review, Cancer Epidemiol Biomarkers Prev, 14, 467, 10.1158/1055-9965.EPI-04-0551

Herrero, 2003, Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study, J Natl Cancer Inst, 95, 1772, 10.1093/jnci/djg107

Pfister, 2003, Chapter 8: Human papillomavirus and skin cancer, J Natl Cancer Inst Monogr, 31, 52, 10.1093/oxfordjournals.jncimonographs.a003483

Scott, 2002, Human papillomavirus 16 and 18 expression in conjunctival intraepithelial neoplasia, Ophthalmology, 109, 542, 10.1016/S0161-6420(01)00991-5

Gillison, 2003, Chapter 9: Role of mucosal human papillomavirus in non-genital cancers, J Natl Cancer Inst Monogr, 57, 10.1093/oxfordjournals.jncimonographs.a003484

Castellsagué, 2003, Chapter 3: Cofactors in human papillomavirus carcinogenesis—role of parity, oral contraceptives, and tobacco smoking, J Natl Cancer Inst Monogr, 20, 10.1093/oxfordjournals.jncimonographs.a003477

Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006;118:1481–95.

Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical cancer and 33,542 women without cervical cancer from 25 epidemiological studies. Int J Cancer 2006;119:1108–24.

IARC Technical reports N3. Tobacco smoke and involuntary smoking. IARC Press, 2004.

Cogliano, 2005, Carcinogenicity of combined oestrogen–progestagen contraceptives and menopausal treatment, Lancet Oncol, 6, 552, 10.1016/S1470-2045(05)70273-4

Smith, 2003, Cervical cancer and the use of hormonal contraceptives: a systematic review, Lancet, 361, 1159, 10.1016/S0140-6736(03)12949-2

Smith, 2002, Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer, J Natl Cancer Inst, 94, 1604, 10.1093/jnci/94.21.1604

Smith, 2004, Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study, Int J Cancer, 111, 431, 10.1002/ijc.20257

Castle, 2003, Chapter 4: Genital tract infections, cervical inflammation, and antioxidant nutrients—assessing their roles as human papillomavirus cofactors, J Natl Cancer Inst Monogr, 31, 29, 10.1093/oxfordjournals.jncimonographs.a003478

Palefsky, 2003, Chapter 6: Immunosuppression and co-infection with HIV, J Natl Cancer Inst Monogr, 31, 41, 10.1093/oxfordjournals.jncimonographs.a003481

Garcia-Closas, 2005, The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence, Int J Cancer, 117, 629, 10.1002/ijc.21193